Changes and significance of serum ubiquitin carboxyl-terminal hydrolase L1 and glial fibrillary acidic protein in patients with glioma

doi:10.12998/wjcc.v11.i14.3158

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 14

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2528)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-4) series.

Item

Count

PDF

136

WORD

HTML

1101

Figures (1-1)

314

Tables (1-4)

310

Sum=1885

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

172

Download

471

Sum=643

May 16, 2023 (publication date) through Feb 14, 2025

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Control Study

World J Clin Cases. May 16, 2023; 11(14): 3158-3166
Published online May 16, 2023. doi: 10.12998/wjcc.v11.i14.3158

Table 1 Comparison of serum ubiquitin carboxy-terminal hydrolase L1 and glial fibrillary acidic protein levels between the glioma and control groups

Group	n	Time	UCH-L1 (pg/mL)	GFAP (ng/L)
Glioma group	91	Preoperative	96.89 ± 17.15^a	16.69 ± 2.16^a
		3 d after surgery	72.15 ± 12.33^a^,^d	7.53 ± 1.74^a^,^d
Control group	60		60.17 ± 10.78	1.16 ± 0.25

^aP < 0.05 vs the control group.

^dP < 0.05 vs the glioma group three days after surgery.

UCH-L1: Ubiquitin carboxy-terminal hydrolase L1; GFAP: Glial fibrillary acidic protein.

Citation: Zhu QH, Wu JK, Hou GL. Changes and significance of serum ubiquitin carboxyl-terminal hydrolase L1 and glial fibrillary acidic protein in patients with glioma. World J Clin Cases 2023; 11(14): 3158-3166
URL: https://www.wjgnet.com/2307-8960/full/v11/i14/3158.htm
DOI: https://dx.doi.org/10.12998/wjcc.v11.i14.3158